Clinical Trials Logo

Filter by:
  • Completed  
  • Page [1] ·  Next »
NCT ID: NCT06330714 Completed - Clinical trials for Chronic Disease of Cardiovascular System

Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements

REMOTE-HUB-1
Start date: July 1, 2018
Phase:
Study type: Observational

This is planned as a feasibility study. The primary objective is to evaluate a specially designed patient monitoring software Vitalbeat and standard mobile device hub termed Intel Health Application Platform (IHAP) in terms of its reliability, seamless data transmission and early data availability to the physician to improve patient physician interaction. The second objective is assessing patient response to use of mobile device monitoring and patient self-monitoring skills to transmit vital signs data using the IHAP wireless home hub device

NCT ID: NCT06329427 Completed - Clinical trials for Automated Clinical Documentation

Dragon Ambient eXperience (DAX) Copilot Evaluation

DAX
Start date: June 19, 2023
Phase: N/A
Study type: Interventional

AI solutions like, Dragon Ambient eXperience (DAX) Copilot (Nuance/Microsoft), hold the potential to significantly enhance provider and patient interactions and alleviate pain points that contribute to burn out. Atrium Health was the first healthcare system in the world to pilot Nuance's DAX Copilot intelligence (AI) enabled scribe software, which synthesizes a draft clinic note by "listening" to the conversation between a provider and patient. After 180 days of use by primary care clinicians and advanced practice providers (APPs), along with a control group, the investigators assess provider satisfaction, patient experience, and provider efficiency through qualitative and quantitative methods.

NCT ID: NCT06329388 Completed - Child Development Clinical Trials

Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns

Start date: January 18, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of type X collagen concentration in urine, height via a stadiometer, and body composition using an INBODY device.

NCT ID: NCT06329258 Completed - Psoriasis Clinical Trials

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Start date: December 6, 2022
Phase: Phase 4
Study type: Interventional

combination deucravacitinib and enstilar foam

NCT ID: NCT06326931 Completed - Clinical trials for Meibomian Gland Dysfunction

Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction

Start date: June 24, 2022
Phase: Phase 4
Study type: Interventional

This study aimed to assess the treatment outcome differences between a single, in-office bilateral treatment with the thermal pulsation system and twice-daily, 10-minute applications of the warm compress mask at home for 8 weeks.

NCT ID: NCT06326814 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy Adults

Start date: October 11, 2021
Phase: Phase 1
Study type: Interventional

Primary objective - The tolerability and safety of SAR443809 Secondary - The PK parameters of SAR443809 - The PD activity of SAR443809 - The immunogenicity of SAR443809

NCT ID: NCT06320470 Completed - Chronic Pain Clinical Trials

MIVetsCan: Can-Coach Trial (Phase 1)

Start date: August 7, 2023
Phase: N/A
Study type: Interventional

The goal of the MIVetsCan Can-Coach Trial is to pilot and modify a trial of four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.

NCT ID: NCT06320327 Completed - Muscle Soreness Clinical Trials

Topical CBD's Effects on Soreness and Performance

Start date: August 23, 2022
Phase: N/A
Study type: Interventional

Exercise-induced muscle damage (EIMD) results from unaccustomed exercise and can lead to delayed onset muscle soreness (DOMS). Impairments associated with EIMD and DOMS can result in moderate-to-severe discomfort and hindered performance. Recently, a compound derived from the cannabis plant, cannabidiol (CBD), has been used as a recovery tool for EIMD and DOMS. Despite the rising popularity of CBD products, their effectiveness in mitigating EIMD and DOMS is unknown. Specifically, to the investigators' knowledge, no clinical trials have been completed to assess the effects of topical CBD cream application on soreness, recovery and performance. Therefore, the purpose of the present study was to investigate the effects of CBD cream on DOMS and performance after an intensive lower-body exercise protocol. Specifically, the study's aims were: Aim 1: To assess the effect of topical CBD cream administration on muscle soreness following fatiguing exercise. Hypothesis 1: CBD cream would decrease perceived muscle soreness when compared to a placebo or control (no cream) group. Aim 2: To assess the effect of topical CBD cream administration on muscular performance following fatiguing exercise. Hypothesis 2: Recovery of muscular power would be quicker when CBD cream is applied, compared to a placebo or control (no cream) group. Aim 3: To assess if topical CBD cream has a localized (if any) or systemic effect on muscle soreness. Hypothesis 3: Improvements in muscle soreness would only be observed in localized muscles around where the CBD cream was applied.

NCT ID: NCT06314516 Completed - Esophageal Cancer Clinical Trials

Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes

INSPECT
Start date: December 27, 2017
Phase:
Study type: Observational

Prospective multicenter longitudinal (observational) study recruiting from tertiary centers for the surgical management of esophageal cancer; Virginia Mason Medical Center (Seattle, USA) and St Mary's Hospital (Imperial College, London, UK). This is intended to be a pilot study.

NCT ID: NCT06311370 Completed - ADHD Clinical Trials

Acceptability, Feasibility, and Development of an AI Driven, Multi-sensor, Non-invasive Digital Mental Health Platform in Children With ADHD and Emotional Symptoms

Start date: August 9, 2023
Phase:
Study type: Observational

This is an observational study collecting data using a wearable to measure the biometric features in youth with Attention deficit hyperactivity disorder(ADHD) and Autism.